New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic’s new vessel sealer, Quest’s brain infection test gain FDA market go-ahead.
You may also be interested in...
Medtronic Builds Surgical Device Offerings Via Salient, Peak Acquisitions
Medtronic will expand its energy-based surgical equipment offerings through its purchase of privately-held Salient Surgical Technologies and Peak Surgical under separate agreements valued at a combined $645 million, announced July 7.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.